Latest news and updates about the Medicare and pharmacy industries.

May 17: Pharmacy Groups Respond to New Drug Pricing Rule, Why Many Patients Decline Statins, and More

Posted on in by Amplicare Team

Here’s the latest pharmacy and healthcare news to know:

1. Two pharmacy industry bodies have expressed displeasure with a final drug pricing rule aimed at lowering drug prices. In a statement, the National Community Pharmacists Association and the National Association of Chain Drug Stores noted their frustration with the rule’s failure to include pharmacy DIR fee reform. According to the statement, DIR fees have been used by plans to increase beneficiary drug costs and reform should take effect as soon as possible for the benefit of seniors and community pharmacies.
Read more from

2. Many patients not on statins were never offered one by their healthcare provider, says a new study published in the Journal of American Heart Association. The study, which set out to discover why patients decline statin therapy, also found fear of possible adverse effects to be a leading reason. The complicated nature of clinical guidelines for statin therapy and the limited time providers have with patients were noted as two reasons why providers may not prescribe a statin.
Read more from APhA.

3. The Trump administration is reportedly considering plans to demand insurers publicize the negotiated rates they pay for services in order to increase price disclosure across the healthcare industry. The plans would also require that doctors and hospitals disclose the total price of care before patients receive services or treatment, regardless of whether or not the provider is in the patient’s insurance network.
Read more from The Wall Street Journal.

4. Rural organizations are getting more money to combat the opioid crisis. This week, the Health Resources and Services Administration awarded $24 million to 120 organizations across 40 states. Recipients, including hospitals, will receive $200,000 for one year to form partnerships with local communities and develop plans to prevent and reduce opioid use in high-risk communities.
Read more from

5. As digital healthcare continues to grow, new research suggests that consumers with a positive outlook on technology will be more likely to adopt it. According to research from Penn State University, consumers are more likely to trust digital healthcare if they trust technology, and their ability to use it, in general. The research focused on consumers’ willingness to accept and trust various digital providers, including virtual nurses and doctors.
Read more from Consumer Affairs.

Other Articles